Missouri Lawmakers Approve Psychedelics Bills To Expand Access To And Research On Psilocybin And Ibogaine

Missouri lawmakers have approved legislation aimed at expanding therapeutic access to and research on psychedelics such as psilocybin and ibogaine for adults and military veterans.

On Wednesday, members of the House Emerging Issues Committee passed two psychedelics proposals—combining two psilocybin- and two ibogaine-focused bills from Reps. Matthew Overcast (R) and Rep. Richard West (R)—that would take a series of steps to fund psychedelics studies, prepare for federal approval of novel therapeutics and create ...

Continue Reading →

Veterans urge TN lawmakers to fund trials of psychoactive drug

Tennessee lawmakers are weighing whether to fund clinical trials of ibogaine, a psychedelic compound advocates say could help veterans and others with PTSD and addiction.

The Helping Open Pathways to Effective (HOPE) Treatment Act was introduced in January and remains under consideration in both Senate and House committees. Advocates rallied for action on the proposal at the state Capitol Feb. 24.

Ibogaine, pronounced i-bow-gain, is illegal for use ...

Continue Reading →
The Jerusalem Post - Israel News

Israeli pharma shakes industry with breakthrough drug

Treatment-resistant depression (TRD) is currently considered one of the most significant challenges in psychiatry: Millions of patients do not respond adequately to existing medications, alongside heavy costs for healthcare systems and ongoing functional loss.

Against this backdrop, the Israeli biopharma company PsyRx is developing an innovative combination drug that seeks to address one of the main failure points of antidepressant treatments – the long time until a significant clinical effect ...

Continue Reading →
Page 9 of 137 «...7891011...»
UA-77446339-1